Giuseppe Carli

1.5k total citations
18 papers, 272 citations indexed

About

Giuseppe Carli is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, Giuseppe Carli has authored 18 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Hematology and 6 papers in Genetics. Recurrent topics in Giuseppe Carli's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Platelet Disorders and Treatments (5 papers). Giuseppe Carli is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Platelet Disorders and Treatments (5 papers). Giuseppe Carli collaborates with scholars based in Italy, Sweden and Croatia. Giuseppe Carli's co-authors include Francesco Rodeghiero, Carlo Visco, Omar Perbellini, Maria Teresa Scupoli, Giuseppe Todeschini, Cristina Tecchio, Olivia Marini, Marco A. Cassatella, Adriana Cassaro and Michele Merli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

Giuseppe Carli

17 papers receiving 269 citations

Peers

Countries citing papers authored by Giuseppe Carli

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Carli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Carli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Carli more than expected).

Fields of papers citing papers by Giuseppe Carli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Carli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Carli. The network helps show where Giuseppe Carli may publish in the future.

Co-authorship network of co-authors of Giuseppe Carli

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Carli. A scholar is included among the top collaborators of Giuseppe Carli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Carli. Giuseppe Carli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study 2025 ·Annals of Hematology ·Alessandra D’Addio, Michela Rondoni, Marzia Salvucci, Giovanni Marconi, Massimiliano Bonifacio, (unknown), Omar Perbellini, Giuseppe Carli, Patrizia Tosi, (unknown), Giovanni Poletti, (unknown), Marco Rosetti, Elisabetta Fabbri, Chiara Zingaretti, Alessandro Lucchesi, Maria Teresa Bochicchio, Giorgia Simonetti, Mauro Krampera, (unknown)	0
2	POS1517 MICROANGIOPATHY, INDEPENDENT RISK FACTOR FOR DAMAGE ACCRUAL IN ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE MULTI-CENTER STUDY 2023 ·Annals of the Rheumatic Diseases ·Ariela Hoxha, Giuseppe Carli, A. Calligaro, T. Del Ross, Maria Favarò, Marta Tonello, Alberto Tosetto, Andrea Doria, Paolo Simioni	1
3	Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Stefano Capri, Giuseppe Carli, Sergio Siragusa	1
4	Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort 2023 ·Hematology ·Alessandro Lucchesi, (unknown), Vickie McDonald, Adrian C. Newland, (unknown), Daniel Eriksson, Koo Wilson, Giulio Giordano, Giuseppe Carli, (unknown), (unknown), (unknown), Mariasanta Napolitano	6
5	Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia 2022 ·British Journal of Haematology ·Marco Pizzi, Fabrizio Vianello, Gianni Binotto, Nicola Vianelli, Giuseppe Carli, Giuseppe Auteri, Ilaria Nichele, Marta Sbaraglia, (unknown), Federico Scarmozzino, (unknown), (unknown), (unknown), Vincenza Guzzardo, Irene Bertozzi, (unknown), Emanuele S. G. d'Amore, Elena Sabattini, Angelo Paolo Dei Tos	10
6	Evaluation of Coaguchek<sup>® </sup>Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study 2022 ·SHILAP Revista de lepidopterología ·Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, (unknown), Giuseppe Carli, Ilaria Nichele, (unknown), (unknown), Emilia Antonucci, Gualtiero Palareti	1
7	Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study 2019 ·Blood ·Carlo Visco, Francesco Rodeghiero, Alessandra Romano, (unknown), Michele Merli, (unknown), Stefano Volpetti, Roberto Santi, Giuseppe Carli, Elisa Lucchini, Francesco Passamonti, Alessandro Rambaldi, Giovanna Motta, Alessandra Borchiellini, Emanuele S.G. dʼAmore, Marco Ruggeri	18
8	Mantle Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study 2019 ·HemaSphere ·Lucia Morello, Sara Rattotti, Laura Giordano, Mats Jerkeman, Tom van Meerten, Katarzyna Krawczyk, (unknown), Dario Marino, Simone Ferrero, Michał Szymczyk, Igor Aurer, Tarec Christoffer El‐Galaly, Alice Di Rocco, Carlo Visco, Giuseppe Carli, Irene Defrancesco, Carmelo Carlo‐Stella, Martin Dreyling, Armando Santoro, Luca Arcaini	11
9	Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists 2017 ·Annals of Hematology ·Francesco Rodeghiero, Giuseppe Carli	29
10	Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 2016 ·Annals of Hematology ·Giuseppe Carli, Carlo Visco, Erika Falisi, Omar Perbellini, Elisabetta Novella, Ilaria Giaretta, Isacco Ferrarini, (unknown), Alberta Alghisi, Achille Ambrosetti, Francesco Rodeghiero	14
11	Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 2016 ·World Journal of Gastroenterology ·Michele Merli, Giuseppe Carli, Luca Arcaini, Carlo Visco	19
12	Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 2016 ·Oncotarget ·Olivia Marini, (unknown), (unknown), Adriana Cassaro, Giovanni Malerba, Giuseppe Todeschini, Omar Perbellini, Maria Teresa Scupoli, Giuseppe Carli, (unknown), Marco A. Cassatella, Patrizia Scapini, Cristina Tecchio	74
13	Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study 2015 ·Leukemia & lymphoma ·Annalisa Arcari, Annalisa Chiappella, Michele Spina, Luca Zanlari, Patrizia Bernuzzi, (unknown), Monica Tani, Roberto Marasca, Maria Giuseppina Cabras, Renato Zambello, Alberto Santagostino, Fiorella Ilariucci, Giuseppe Carli, Pellegrino Musto, (unknown), Dario Marino, (unknown), Massimo Gentile, Maria Christina Cox, Daniele Vallisa	22
14	Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 2015 ·Oncotarget ·Carlo Visco, Erika Falisi, Ken H. Young, Michela Pascarella, Omar Perbellini, Giuseppe Carli, Elisabetta Novella, Davide Rossi, Ilaria Giaretta, Chiara Cavallini, Maria Teresa Scupoli, Anita De Rossi, Emanuele S.G. dʼAmore, Mario Rassu, Gianluca Gaïdano, Giovanni Pizzolo, Achille Ambrosetti, Francesco Rodeghiero	21
15	The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 2014 ·Leukemia Research ·Giovanna De Matteis, Roberta Zanotti, Sabrina Colarossi, Caterina De Benedittis, Andrés C. García‐Montero, Massimiliano Bonifacio, (unknown), (unknown), Beatrice Caruso, Elisa Paviati, Giuseppe Carli, Omar Perbellini, Alberto Zamò, Patrizia Bonadonna, Giovanni Pizzolo, Gian Cesare Guidi, Giovanni Martinelli, Simona Soverini	21
16	Safety and Efficacy of Rituximab Plus Bendamustine in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients 2014 ·Blood ·Annalisa Arcari, Annalisa Chiappella, (unknown), Luca Zanlari, Monica Tani, Roberto Marasca, Maria Giuseppina Cabras, Michele Spina, Alberto Santagostino, Fiorella Ilariucci, Giuseppe Carli, Pellegrino Musto, (unknown), Dario Marino, (unknown), Massimo Gentile, Maria Christina Cox, (unknown), Daniele Vallisa	1
17	PBX/E2A transcript positive B-lymphoblastic leukemia (B-ALL) presenting with bilateral renal and myocardial involvement: a case report. 2013 ·Giuseppe Carli, (unknown), Massimiliano Bonifacio, (unknown), Cristina Tecchio, (unknown), Giovanni Pizzolo, Achille Ambrosetti	1
18	Intensive short‐term chemotherapy regimen induces high remission rate (over 90%) and event‐free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia 2011 ·American Journal of Hematology ·Giuseppe Todeschini, Massimiliano Bonifacio, Cristina Tecchio, Rita Balter, Giuseppe Carli, Piero Maria Stefani, Fausto Adami, Alberto Zamò, Angelo Paolo Dei Tos, Filippo Marino, Filíppo Gherlinzoni, Pierluigi Marradi, Gianpietro Semenzato, Giovanni Pizzolo	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact